LATS2 and cancer: More broadly, the ability of LATS2 to modulate master regulators of lipid metabolism such as PPARγ and SREBP (Aylon et al, 2016) expands the functional consequences of the deregulation of Hippo pathway components in cancer and may indicate a metabolic Achilles' heel of particular tumors.